Skip to main content
SpringerLink
Log in

mTOR-mediated differentiation and maintenance of suppressive T cells at the center stage of IPEX treatment

  • CORRESPONDENCE
  • Published:
Immunologic Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Data availability

No datasets were generated or analysed during the current study.

References

  1. Passerini L, Barzaghi F, Curto R, Sartirana C, Barera G, Tucci F, Albarello L, Mariani A, Testoni PA, Bazzigaluppi E, Bosi E, Lampasona V, Neth O, Zama D, Hoenig M, Schulz A, Seidel MG, Rabbone I, Olek S, Roncarolo MG, Cicalese MP, Aiuti A, Bacchetta R. Treatment with rapamycin can restore regulatory T-cell function in IPEX patients. J Allergy Clin Immunol. 2020;145(4):1262-1271.e13. https://doi.org/10.1016/j.jaci.2019.11.043.

    Article  PubMed  CAS  Google Scholar 

  2. Kempkes RWM, Joosten I, Koenen HJPM, He X. Metabolic pathways involved in regulatory T cell functionality. Front Immunol. 2019;3(10):2839. https://doi.org/10.3389/fimmu.2019.02839.

    Article  CAS  Google Scholar 

  3. Khan MM, Kalim UU, Khan MH, Lahesmaa R. PP2A and its inhibitors in helper T-cell differentiation and autoimmunity. Front Immunol. 2022;5(12):786857. https://doi.org/10.3389/fimmu.2021.786857.

    Article  CAS  Google Scholar 

  4. Gianchecchi E, Fierabracci A. Inhibitory receptors and pathways of lymphocytes: the role of PD-1 in treg development and their involvement in autoimmunity onset and cancer progression. Front Immunol. 2018;17(9):2374. https://doi.org/10.3389/fimmu.2018.02374.

    Article  CAS  Google Scholar 

  5. Chi H. Regulation and function of mTOR signalling in T cell fate decisions. Nat Rev Immunol. 2012;12(5):325–38. https://doi.org/10.1038/nri3198.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  6. Procaccini C, De Rosa V, Galgani M, Abanni L, Calì G, Porcellini A, Carbone F, Fontana S, Horvath TL, La Cava A, Matarese G. An oscillatory switch in mTOR kinase activity sets regulatory T cell responsiveness. Immunity. 2010;33(6):929–41. https://doi.org/10.1016/j.immuni.2010.11.024.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  7. Stathopoulou C, Gangaplara A, Mallett G, Flomerfelt FA, Liniany LP, Knight D, Samsel LA, Berlinguer-Palmini R, Yim JJ, Felizardo TC, Eckhaus MA, Edgington-Mitchell L, Martinez-Fabregas J, Zhu J, Fowler DH, van Kasteren SI, Laurence A, Bogyo M, Watts C, Shevach EM, Amarnath S. PD-1 inhibitory receptor downregulates asparaginyl endopeptidase and maintains Foxp3 transcription factor stability in induced regulatory T cells. Immunity. 2018;49(2):247-263.e7. https://doi.org/10.1016/j.immuni.2018.05.006.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  8. Blank C, Brown I, Marks R, Nishimura H, Honjo T, Gajewski TF. Absence of programmed death receptor 1 alters thymic development and enhances generation of CD4/CD8 double-negative TCR-transgenic T cells. J Immunol. 2003;171(9):4574–81. https://doi.org/10.4049/jimmunol.171.9.4574.

    Article  PubMed  CAS  Google Scholar 

  9. Xie Y, Lei X, Zhao G, Guo R, Cui N. mTOR in programmed cell death and its therapeutic implications. Cytokine Growth Factor Rev. 2023;71–72:66–81. https://doi.org/10.1016/j.cytogfr.2023.06.002.

    Article  PubMed  CAS  Google Scholar 

  10. Wong M, La Cava A, Hahn BH. Blockade of programmed death-1 in young (New Zealand Black x New Zealand White)F1 mice promotes the suppressive capacity of CD4+ regulatory T cells protecting from lupus-like disease. J Immunol. 2013;190(11):5402–10. https://doi.org/10.4049/jimmunol.1202382.

    Article  PubMed  CAS  Google Scholar 

  11. Apostolidis SA, Rodríguez-Rodríguez N, Suárez-Fueyo A, Dioufa N, Ozcan E, Crispín JC, Tsokos MG, Tsokos GC. Phosphatase PP2A is requisite for the function of regulatory T cells. Nat Immunol. 2016;5:556–64. https://doi.org/10.1038/ni.3390.

    Article  CAS  Google Scholar 

  12. Tai X, Van Laethem F, Pobezinsky L, Guinter T, Sharrow SO, Adams A, Granger L, Kruhlak M, Lindsten T, Thompson CB, Feigenbaum L, Singer A. Basis of CTLA-4 function in regulatory and conventional CD4(+) T cells. Blood. 2012;119(22):5155–63. https://doi.org/10.1182/blood-2011-11-388918.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  13. Bai A, Guo Y. Acid sphingomyelinase mediates human CD4+ T-cell signaling: potential roles in T-cell responses and diseases. Cell Death Dis. 2017;8(7):e2963. https://doi.org/10.1038/cddis.2017.360.

    Article  MathSciNet  PubMed  PubMed Central  CAS  Google Scholar 

  14. Schildberg FA, Klein SR, Freeman GJ, Sharpe AH. Coinhibitory pathways in the B7-CD28 ligand-receptor family. Immunity. 2016;44(5):955–72. https://doi.org/10.1016/j.immuni.2016.05.002.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  15. Gabriel SS, Tsui C, Chisanga D, Weber F, Llano-León M, Gubser PM, Bartholin L, Souza-Fonseca-Guimaraes F, Huntington ND, Shi W, Utzschneider DT, Kallies A. Transforming growth factor-β-regulated mTOR activity preserves cellular metabolism to maintain long-term T cell responses in chronic infection. Immunity. 2021;54(8):1698-1714.e5. https://doi.org/10.1016/j.immuni.2021.06.007.

    Article  PubMed  CAS  Google Scholar 

Download references

Funding

I acknowledge the financial support of Coordenação de Aperfeiçoamento de Pessoal de Ensino Superior-CAPES; Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro- FAPERJ E-26/200.628/2022.

Author information

Authors and Affiliations

  1. Laboratory of Immunoreceptors and Signaling, Instituto de Biofísica Carlos Chagas Filho, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil

    Rafael Cardoso Maciel Costa Silva

Authors
  1. Rafael Cardoso Maciel Costa Silva
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Silva R.C.M.C. wrote the letter.

Corresponding author

Correspondence to Rafael Cardoso Maciel Costa Silva.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics approval

Not applicable.

Consent to participate

Not applicable.

Declaration of generative AI and AI-assisted technologies in the writing process: statement

During the preparation of this work, the author did not use any generative AI and AI-assisted technologies in the writing process. The author takes full responsibility for the content of the publication.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Silva, R.C.M.C. mTOR-mediated differentiation and maintenance of suppressive T cells at the center stage of IPEX treatment. Immunol Res (2024). https://doi.org/10.1007/s12026-024-09472-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12026-024-09472-x

Search

Navigation